stockrow
Friday 6 November 2026
Export DH’s income statement to Excel — free account
Definitive Healthcare Corp.
DH Healthcare Health Information Services
Definitive Healthcare Corp.’s revenue for fiscal 2025 (year ended December 2025) was $241.5 million, down 4.24% from fiscal 2024.
- Revenue
- −8.99%
- EPS
- +71.4%
- Free cash flow
- −32.6%
- Total debt
- −5.03%
Quarter to September 2026, against a year earlier
1.16
0.03
+2.65%
Follow DH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 6 | 5 |
| (28.18%) | (54.36%) | (56.15%) | (54.40%) | ||
| (15.23%) | (25.74%) | (26.55%) | (25.28%) | ||
ROIC |
(38.62%) | (85.82%) | (92.23%) | (95.39%) | |
Return on Tangible Assets |
(122.41%) | (142.95%) | (133.71%) | (116.72%) | |
Average Days of Receivables |
78.55 | 59.66 | 48.58 | 47.38 | |
Free Cash Flow per Share |
0.35 | 0.26 | 0.27 | 0.23 | |
Free Cash Flow |
37.06 | 27.06 | 28.56 | 24.19 | |
Capital Expenditures |
(16.72) | (12.22) | (12.86) | (12.97) | |
| Other line items | |||||
Cash ROIC |
5.11% | 5.09% | 5.37% | 4.51% | |
Accounts Receivable Turnover |
4.59 | 5.82 | 6.80 | 7.12 | |
Accounts Payable Turnover |
8.11 | 8.02 | 9.27 | 7.78 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
22.53 | 38.51 | 28.71 | 37.99 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.05) | (0.01) | (0.01) | (0.02) | |
Research and Development Expense of Revenue |
14.40% | 13.42% | 13.22% | 13.14% | |
Selling, General and Administrative Expense of Revenue |
55.18% | 55.40% | 55.36% | 56.13% | |
Share Based Compensation of Revenue |
12.07% | 11.35% | 10.88% | 10.63% | |
Interest Coverage |
(19.87) | (20.97) | (21.88) | (22.22) | |
Operating CF/Net income |
(0.39) | (0.23) | (0.25) | (0.24) | |
Depreciation/Fixed assets |
21.18 | 20.91 | 19.50 | 0.00 | |
Capex/Depreciation |
(0.06) | (0.04) | (0.04) | 0.00 | |
Revenue per Share |
2.26 | 2.28 | 2.20 | 2.13 | |
Operating CF per Share |
0.50 | 0.38 | 0.39 | 0.35 | |
Capex per Share |
(0.16) | (0.12) | (0.12) | (0.12) | |
Capex to Sales |
0.07 | 0.05 | 0.06 | 0.06 |
Columns are period end dates · fundamentals updated 5 Nov 2026